With the analysis among 151 patents, we discovered top 19 key players by total patent application. Adimab LLC, Merck Sharp & Dohme Corp., Bayer Pharma AG are dominant in this area. They take 70.20% of the total patent filing.
New Hampshire, United States
Patent: 49
New Jersey, United States
Patent: 32
Berlin, Germany
Patent: 25
New Jersey, United States
Patent: 16
Shanghai Shi, China
Patent: 15
Jiangsu Sheng, China
Patent: 12
Hovedstaden, Denmark
Patent: 11
Zuid-Holland, Netherlands
Patent: 7
Jiangsu Sheng, China
Patent: 6
Noord-Brabant, Netherlands
Patent: 6
No data, please try another search term
With the analysis among related 60 patents applied in the last 5 years. We discover 12 most active companies in this area. The fast-growing Adimab LLC, Merck Sharp & Dohme Corp., Suzhou Ruibo Biological Technology Co Ltd take 70.00% of patent filing during this period.
New Hampshire, United States
Patent: 17
New Jersey, United States
Patent: 13
Jiangsu Sheng, China
Patent: 12
Shanghai Shi, China
Patent: 10
Jiangsu Sheng, China
Patent: 6
New Jersey, United States
Patent: 4
undefined undefined
Patent: 1
Shanghai Shi, China
Patent: 1
With the analysis among related 60 patents in last 5 years, we discover 4 new entrants. Suzhou Ruibo Biological Technology Co Ltd, Suzhou Alphamab Co. Ltd., Shanghai Tuojie Biotechnology Co., Ltd. are the most active new entrants in this area.
Jiangsu Sheng, China
Patent: 12
Jiangsu Sheng, China
Patent: 6
Shanghai Shi, China
Patent: 1
Shanghai Shi, China
Patent: 1
With the analysis among 4 patents, we discovered top 3 universities and scientific research institutions by total patent application.
Tennessee, United States
Patent: 2
Beijing Shi, China
Patent: 1